ZALTRAP: payments to doctors
Payments that named ZALTRAP as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $24K
- Providers
- 7
- Transactions
- 15
- Average per transaction
- $1,629
The per-transaction average — $1,629 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 7 providers the average total is $3,490, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Sanofi | $17,566 | 71.9% |
| Sanofi-aventis U.S. LLC | $6,864 | 28.1% |